JESSICA SANDER: Open Payments
NPI 1477178275 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,262 in 123 payments from 22 companies in 2025. Trend: 2023 $5,099 · 2024 $4,824 · 2025 $5,262
Food & beverage: $4,262Consulting: $1,000
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 18 | $1,700 |
| ABBVIE INC. | 20 | $552 |
| UCB, Inc. | 17 | $459 |
| GENZYME CORPORATION | 9 | $375 |
| Incyte Corporation | 3 | $337 |
| Janssen Biotech, Inc. | 9 | $253 |
| Galderma Laboratories, L.P. | 5 | $211 |
| Regeneron Healthcare Solutions, Inc. | 9 | $189 |
| Novartis Pharmaceuticals Corporation | 5 | $158 |
| PFIZER INC. | 4 | $150 |
Products named: Zoryve, DUPIXENT, Bimzelx, SKYRIZI, Opzelura, TREMFYA, NEMLUVIO, RINVOQ.
Industry payments across FL — which companies pay providers there.
